Novel antibody drug conjugate TORL-1-23 shows preliminary antitumour activity in heavily-pretreated ovarian, endometrial, and testicular cancers

ESMO 2024: Latest in bladder cancer - expert review

Understanding the use of PARPi combinations to treat patients with mCRPC

Enzalutamide treatment boosted by Radium-223 in mCRPC

ESMO 2024: Optimising the personalisation of prostate cancer treatment

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

NKT2152 demonstrates anti-tumor activity in heavily pretreated advanced clear cell RCC

Nivolumab plus ipilimumab improves efficacy versus standard of care in non-clear-cell renal cell carcinomas

Repeat immune checkpoint inhibitor therapy not recommended for aRCC

Assessment of suicide risk in cancer patients

Association of adult attachment with delays in accessing specialist care in women with ovarian cancer

Cancer journeys: Research from India